AdaptHealth Corp. provides patient-centered healthcare-at-home solutions, including home medical equipment, medical supplies, and related services. The company operates through four reportable segments: Sleep Health, which offers continuous positive airway pressure and BiLevel services for obstructive sleep apnea; Respiratory Health, which supplies oxygen and home mechanical ventilation equipment for chronic respiratory diseases; Diabetes Health, which provides continuous glucose monitors and insulin pumps; and Wellness at Home, which delivers durable medical equipment and supplies to patients discharged from acute care facilities. AdaptHealth serves beneficiaries of Medicare, Medicaid, and commercial insurance payors across all 50 states. The company receives referrals from acute care hospitals, sleep laboratories, pulmonologist and endocrinologist offices, skilled nursing facilities, and primary care providers. AdaptHealth partners with OneHome for durable medical equipment and medical supply needs. The company also operates the AdaptHealth Marketplace, an online retail store for out-of-pocket purchases of home medical equipment and wellness supplies, and StorkPump.com for breast pump and maternity care products.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Distribution Homepage adapthealth.com
Sector Healthcare IR page adapthealth.com/pages/investor-relations
Tags
home medical equipment, sleep therapy, respiratory care, diabetes management, durable medical equipment, medical supplies, home healthcare, patient care, chronic disease management, outpatient care, OneHome, AdaptHealth Marketplace, StorkPump.com, Diabetes.AdaptHealth.com
Press page adapthealth.com/pages/latest-news

Metrics

Valuation  
Market cap $ 769.638M
Market cap (USD) $ 769.638M
P/E -10.85
PEG —
P/BV 0.63
P/S 0.24
P/OCF 1.33
P/FCF 9.39
Dividend yield —
Turnover / mcap —
Returns  
ROE -4.6%
ROI -2.2%
ROIC 2.1%
Profit margin -2.2%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 153.7%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 6
Quality score -17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 3.245B 3.261B 3.2B 2.971B 2.455B 1.056B 529.644M —
Net profit -70.794M 90.422M -678.895M 69.316M 156.175M -64.481M -14.996M 2.086M
Free cash flow 219.383M 235.784M 143.203M -17.556M 72.371M 155.879M 39.086M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 9.96 9.52 7.29 19.22 24.46 37.56 10.98 —
Price performance 12m 0.05 0.31 -0.62 -0.21 -0.35 2.42 — —

Filed figures

Figure Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — 53M 78.6M 171M 360M 359M 389M 408M 371M
↳ YoY growth +48.3% +117.6% +110.4% -0.2% +8.3% +4.9% -9.1%
↳ 5y CAGR +49.0% +39.0% +16.7%
Borrowings, current (USD) — 7.09M 1.72M 8.15M 20M 35M 53.4M 16.3M 20.3M
Borrowings, non-current (USD) — 127M 395M 777M 2.18B 2.15B 2.09B 1.96B 1.72B
Lease liabilities (USD) — — — 22.3M 167M 137M 147M 149M 167M
Cash and deposits (USD) 119,821 947,098 76.9M 100M 150M 46.3M 77.1M 110M 106M
Intangible assets (USD) — — 0.00 116M 202M 163M 130M 106M 85.1M
Right-of-use assets (USD) — — — — 148M 130M 110M 106M 112M
Net debt (borrowings + leases - cash) (USD) — 109M 320M 685M 2.22B 2.28B 2.22B 2.02B 1.8B
Cash flow detail
Operating cash flow (USD) — -1.63M 60.4M 196M 276M 374M 481M 542M 602M
Purchases of property, plant and equipment (USD) — -9.95M -21.3M -39.8M -203M -391M -337M -306M -382M
Change in receivables (cash effect) (USD) — -22M -20.2M -29.5M -29.7M -209,000 -28.9M -26.2M 31M
Change in inventories (cash effect) (USD) — 2.31M -1.31M -19.4M -14.9M -6.3M 15.5M -28.1M -11.5M
Change in payables (cash effect) (USD) — -19,732 14.2M 137M -83.4M -57.1M 41M 33.8M 139M
Share buybacks (cash effect) (USD) — — -20M 0.00 0.00 -14M -29.3M 0.00 0.00
Interest paid (cash effect) (USD) — -7.33M -23.1M -35.8M -73.6M -109M -126M -122M -101M
Income taxes paid (cash effect) (USD) — -405,205 -1.32M -7.48M -14.8M -14.9M -14.8M -14.1M -24.3M
Share-based compensation (USD) — 883,373 11.1M 18.7M 25.3M 22.4M 22.5M 14.9M 21.9M
Operating cash flow before change in receivables (USD) — 90.5M 80.6M 225M 305M 374M 510M 568M 571M
Free cash flow (OCF - PPE - intangibles) (USD) — 58.5M 39.1M 156M 72.4M -17.6M 143M 236M 219M
Income detail
Total comprehensive income (USD) — 24.3M -10.3M -69.4M 164M 84.2M -679M 92.7M -68.2M
Comprehensive income to owners (USD) — 23.3M -12.5M -75.1M 162M 80.4M -683M 88.3M -73M
Provision for credit losses (USD) — 15.8M — — — — — — —
Reported May 15, 2018 Mar 6, 2020 Nov 6, 2020 Feb 28, 2023 Feb 28, 2023 Feb 28, 2023 Feb 27, 2024 Feb 25, 2025 Feb 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Nov 03, 2026

Share

Share

CONSHOHOCKEN, Pa. – November 3, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the third quarter ended September 30, 2026.

Third Quarter Business Highlights

  • Made solid progress in the second full quarter of the Company’s exclusive capitated agreement with a large national integrated delivery network, with utilization lower than peak levels and reduced labor costs driving a sequential improvement in contract profitability.
  • Cleared the Hart-Scott-Rodino waiting period for the pending sale of the Company’s Diabetes Health business for $235.0 million in cash, with the transaction on track to close in early 2027, subject to certain regulatory approvals and other customary closing conditions.
  • Signed preferred-provider agreements with four health systems, and broadened its capitated portfolio through two smaller agreements with regional health plans, one new and one expanded.
  • Grew registered myAPP users to more than 615,000, up approximately 88% from year-end 2025, and completed more than 12,600 patient scans with its AI-powered mask-fitting tool.

**
Third Quarter Results**

All comparisons are to the quarter ended September 30, 2025 unless otherwise stated. The amounts presented below reflect the Company’s continuing operations, except for cash flow from operations and free cash flow, which include the cash flows from continuing operations and discontinued operations, see below for further discussion.

  • Net revenue was $745.6 million compared to $672.4 million, an increase of 10.9%.
  • Organic revenue growth of 12.8%, with growth across each of the Company’s reportable segments.
  • Net loss attributable to AdaptHealth Corp. was $168.2 million compared to net income of $10.2 million, largely resulting from a $184.8 million pre-tax write down of goodwill.
  • Adjusted EBITDA was $141.9 million compared to $146.1 million, a decrease of 2.9%.
  • Cash flow from operations was $395.6 million year-to-date 2026, a decrease from $418.6 million during the comparable period in 2025, and free cash flow was $2.6 million year-to-date 2026, compared to $140.1 million during the comparable period in 2025.

**
Management Commentary**

“In the third quarter, we delivered strong organic revenue growth and exceeded our guidance for revenue, Adjusted EBITDA and free cash flow,” said Suzanne Foster, Chief Executive Officer. “Our capitated partnership made a positive contribution to enterprise Adjusted EBITDA, driven by a tighter labor model and lower costs to serve. We also continue to move toward closing the sale of our Diabetes Health business, bringing us closer to a more focused portfolio built around Sleep Health, Respiratory Health and Wellness-at-Home. The business is stabilizing as we work through a period of transformation, and we look forward to carrying that momentum into 2027.”

Financial Outlook

The Company is revising its financial guidance for fiscal year 2026 on a continuing operations basis, which excludes the Diabetes Health business, except for free cash flow, which includes the cash flows from continuing operations and discontinued operations, as follows:

  • Net revenue of $2.88 billion to $2.90 billion, from $2.85 billion to $2.89 billion
  • Adjusted EBITDA of $510 million to $525 million, from $490 million to $520 million
  • Free cash flow of $50 million to $75 million, from $80 million to $120 million

**
Conference Call**

Management will host a teleconference today, Tuesday, November 3, 2026, at 8:30 am ET to discuss the results and business activities with analysts and investors.

Interested parties may participate in the call by dialing: 

When prompted, reference Conference ID: AHCO3Q26

**Webcast registration: Click Here. **

Following the live call, a replay will be available for six months on the Company's website, www.adapthealth.com, under "Investor Relations."

adapthealth logo image footer

AdaptHealth empowers patients to live their best lives.

ABOUT US

PRODUCTS

Wellness at Home

SHOP ONLINE

RESOURCES

ABOUT US

PRODUCTS

Wellness at Home

SHOP ONLINE

RESOURCES

INFORMATION

Copyright © 2026 AdaptHealth, LLC. All Rights Reserved.

Copyright © 2025 AdaptHealth, LLC.
All Rights Reserved.

Skip to main content

Alert: AdaptHealth Notice of Cybersecurity Incident

Alert: AdaptHealth Notice of Cybersecurity Incident

Investor Relations

AHCO $6.10

0%

plus - achomarketplace

Search

About Us

Product & Services

Respiratory Care

Sleep Therapy

Diabetes Care

Wellness at Home

Resources

For Patient

Resources

myAPP

Others

For Providers

Resources

E-Prescribe

Other

Search

Top searches

AdaptHealth — Home









Search

Search

Top searches

Bill Pay

AdaptHealth is proud to partner with OneHome in our shared mission of empowering patients to live their best lives.

Effective June 1, 2026, please contact us at 800-253-0383 for all of your durable medical equipment (DME) and medical supply needs.

We look forward to serving you and supporting your healthcare journey.

Continue to site

You're leaving AdaptHealth.com for our Diabetes Care site.

Continue to Diabetes.AdaptHealth.com?

Cancel

Yes, Continue

You're leaving AdaptHealth.com for StorkPump.com

Our breast pump and maternity care site. Continue to StorkPump.com?

Cancel

Yes, Continue

You're leaving AdaptHealth.com for the AdaptHealth Marketplace.

AdaptHealth Marketplace is an online retail store for customers interested in purchasing home medical equipment and wellness supplies out-of-pocket without using insurance.

Continue to AdaptHealthMarketplace.com?

Cancel

Yes, Continue

BACK TO EARNINGS

AdaptHealth Corp. Announces Third Quarter 2026 Earnings Release Date and Conference Call

Oct 21, 2026

Share

Share

CONSHOHOCKEN, Pa. – October 21, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2026 financial results before the opening of the financial markets on Tuesday, November 3, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors.

Interested parties may participate in the call by dialing:

When prompted, reference Conference ID: AHCO3Q26

**Webcast registration: Click Here **

Following the live call, a replay will be available for six months on the Company's website, www.adapthealth.com under "Investor Relations."

adapthealth logo image footer

AdaptHealth empowers patients to live their best lives.

ABOUT US

PRODUCTS

Wellness at Home

SHOP ONLINE

RESOURCES

ABOUT US

PRODUCTS

Wellness at Home

SHOP ONLINE

RESOURCES

INFORMATION

Copyright © 2026 AdaptHealth, LLC. All Rights Reserved.

Copyright © 2025 AdaptHealth, LLC.
All Rights Reserved.

Sep 08, 2026

Share

Share

PLYMOUTH MEETING, Pa. – September 8, 2026 - AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chief Financial Officer, effective September 9, 2026. Mr. Currie will assume CFO responsibilities from Jason Clemens, who will assist with the transition through October 1, 2026.

Mr. Currie previously served as the CFO for Luminex Corp (Nasdaq: LMNX) for more than 15 years until its sale to DiaSorin in 2021. He has more recently held CFO roles at Health Track Rx from 2025 to 2026 and from Impulse Dynamics from 2022 to 2023, and served as President of the Regenerative Medicine division of 3D Systems (NYSE: DDD) from 2023 to 2025.

Mr. Currie holds an MBA from the McCombs School of Business at the University of Texas at Austin and previously served as an audit manager at Deloitte & Touche.

“We are delighted to welcome Harriss to AdaptHealth and look forward to the meaningful contributions we expect he will make in both the short and long term,” said Suzanne Foster, Chief Executive Officer. “We appreciate Jason’s years of service and are particularly thankful for the strong team and structure he has left for Harriss to build on.”

“I am excited to join AdaptHealth and to lead the finance team through our next phase of growth. In evaluating this opportunity, I saw a strong leadership team, solid financial processes, and a business that has put strategic contracts in place to position itself for meaningful revenue and EBITDA growth. I am truly excited and appreciative of this opportunity,” said Mr. Currie.

adapthealth logo image footer

AdaptHealth empowers patients to live their best lives.

ABOUT US

PRODUCTS

Wellness at Home

SHOP ONLINE

RESOURCES

ABOUT US

PRODUCTS

Wellness at Home

SHOP ONLINE

RESOURCES

INFORMATION

Copyright © 2026 AdaptHealth, LLC. All Rights Reserved.

Copyright © 2025 AdaptHealth, LLC.
All Rights Reserved.

Prompts

AdaptHealth Corp. (ticker AHCO), listed in United States.

Company History

Date Change Detail
Sep 16, 2019 Renamed DFB HEALTHCARE ACQUISITIONS CORP. → ADAPTHEALTH CORP.

ETFs Holding AdaptHealth Corp.

ETF Weight in ETF Shares Market value As of
DSMC 0.56% 69,566 $ 724.878K Jun 30, 2026
WCEO 0.48% 4,425 $ 47.79K Jul 31, 2026
IVSS 0.24% 6,174 $ 64.333K Jun 30, 2026
BSVO 0.21% 664,836 $ 5.01M Nov 18, 2026
ESSC 0.19% 6,321 $ 68.267K Jul 31, 2026
VFVA 0.14% 241,351 $ 1.349M Aug 31, 2026
DFSV 0.07% 2,291,618 $ 18.035M Nov 12, 2026
AVSC 0.06% 239,524 $ 1.852M Nov 16, 2026
VFMF 0.06% 102,133 $ 570.923K Aug 31, 2026
DFAT 0.06% 2,239,006 $ 17.621M Nov 12, 2026
PSC 0.05% 114,757 $ 1.196M Jun 30, 2026
RESM 0.04% 148 $ 1,542.16 Jun 30, 2026
SMDX 0.04% 6,605 $ 51.057K Nov 17, 2026
AVIE 0.01% 261 $ 2,017.53 Nov 16, 2026
DXUV 0.01% 72,058 $ 567.096K Nov 12, 2026
EBI 0.01% 10,246 $ 57.275K Aug 31, 2026
DFAC 0.00% 453,009 $ 3.565M Nov 12, 2026
DCOR 0.00% 148,208 $ 1.166M Nov 12, 2026
DFUV 0.00% 34,063 $ 268.076K Nov 12, 2026
DFAU 0.00% 19,157 $ 150.766K Nov 12, 2026
DFAS 0.00% 23,206 $ 182.631K Nov 12, 2026
DFUS 0.00% 482 $ 3,793.34 Nov 12, 2026